BioMedix Company Profile
BioMedix is a new biotechnology company that specializes in developing and manufacturing high quality, high performance, cutting-edge ELISA assays. At BioMedix, we are committed to providing the most comprehensive panel of high quality research and diagnostic reagents at the most reasonable prices. We offer products covering the areas of research in cytokines and chemokines, adhesion molecules, cancer research, and apoptosis.
Location
Kalymnou 5A
Moschato
Athens
Attica
18345
Greece
Contact
Phone: +30 210 9581143
Fax: +30 210 9581168
Email: info@biomedix.gr
News Articles
Helix BioMedix second quarter revenue decreases 32% to $471,000
Helix BioMedix, Inc., a developer of bioactive peptides, today announced financial results for the second quarter ended June 30, 2012.
BioMedix® Launches Enhanced Non-Invasive Vascular Testing Devices, PADnet® and VEINnet™
ST. PAUL, Minn., Dec. 18, 2012 /PRNewswire/ -- BioMedix, a leader in healthcare IT designed to help manage disease and optimize medical practices, today introduced exciting technology for non-...
Safecode Drug Technologies Receives Investment From Biomedix Ltd
JERUSALEM, January 7, 2013 /PRNewswire/ -- - Israel's publicly-traded (TASE) BioMedix Agrees to Purchase SAFC at 0.15 cents Per Share SafeCode Drug Technologies Corp. (OTCBB: SAFC), a developer of a...
SafeCode Drug Technologies Receives Investment From Biomedix Ltd.
JERUSALEM, Jan. 6, 2013 /PRNewswire/ -- SafeCode Drug Technologies Corp. (OTCBB: SAFC), a developer of a voice recognition drug administration safety application announced today that Israeli's B...
ProGaming Platforms Corp. Executes Share Swap Agreement With BioMedix Ltd.
NEW YORK, February 18, 2013 /PRNewswire/ -- ProGaming Platforms Corp. ( OTCQB: PPTF), an Israeli-based developer of a commercial multiplayer online gaming and reward processing platform, today announ...
Suspect Detection Systems Receives Funding From Israel-Publicly Traded Biomedix Ltd.
NEW YORK, April 3, 2013 /PRNewswire/ -- Funding can support enhancing the Cogito Solution's marketing efforts, that management believe, can assist in Preventing Potential School/Mall Massacres Suspe...
Helix BioMedix Reports Third Quarter 2012 Financial Results
Helix BioMedix, Inc. (OTCQB: HXBM), a developer of bioactive peptides, today announced financial results for the third quarter ended September 30, 2012. Third Quar...
Helix BioMedix Announces Plan for Voluntary Suspension of SEC Reporting Obligations
Helix BioMedix, Inc. (OTCQB: HXBM) (the “Company”), a developer of bioactive peptides, today announced that it has filed a Schedule 13E-3 and related preliminary proxy stateme...
Drugs and Medications
None
PubMed Articles
None
Clinical Trials
None
Companies
KS Biomedix is a biopharmaceutical company with operations in the UK and Canada. It is developing small molecules and biologics for the in vivo diagnosis and treatment of cancer and inflammatory disea...
BioMedix is a new biotechnology company that specializes in developing and manufacturing high quality, high performance, cutting-edge ELISA assays. At BioMedix, we are committed to providing the most...
BioMedix is the fastest growing provider of equipment and services in the market for noninvasive detection of peripheral vascular disease (PVD). Unique technology also links PCP's and Vascular Special...
BioMedix Vascular Solutions, Inc.
Helix BioMedix, Inc. was founded in 1988 with the mission of developing and commercializing small proteins known as bioactive-peptides. We are headquartered in Bothell, Washington and shares of our co...
More Information about "BioMedix" on BioPortfolio
We have published hundreds of BioMedix news stories on BioPortfolio along with dozens of BioMedix Clinical Trials and PubMed Articles about BioMedix for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioMedix Companies in our database. You can also find out about relevant BioMedix Drugs and Medications on this site too.
